Standard

Synthesis and antitumour activity of 4-aminoquinazoline derivatives. / Lipunova, Galina N.; Nosova, Emiliya V.; Charushin, Valery N. et al.
In: Russian Chemical Reviews, Vol. 85, No. 7, 2016, p. 759-793.

Research output: Contribution to journal › Literature review › peer-review

Harvard

Lipunova, GN, Nosova, EV, Charushin, VN & Chupakhin, ON 2016, 'Synthesis and antitumour activity of 4-aminoquinazoline derivatives', Russian Chemical Reviews, vol. 85, no. 7, pp. 759-793. https://doi.org/10.1070/RCR4591

APA

Lipunova, G. N., Nosova, E. V., Charushin, V. N., & Chupakhin, O. N. (2016). Synthesis and antitumour activity of 4-aminoquinazoline derivatives. Russian Chemical Reviews, 85(7), 759-793. https://doi.org/10.1070/RCR4591

Vancouver

Lipunova GN, Nosova EV, Charushin VN, Chupakhin ON. Synthesis and antitumour activity of 4-aminoquinazoline derivatives. Russian Chemical Reviews. 2016;85(7):759-793. doi: 10.1070/RCR4591

Author

Lipunova, Galina N. ; Nosova, Emiliya V. ; Charushin, Valery N. et al. / Synthesis and antitumour activity of 4-aminoquinazoline derivatives. In: Russian Chemical Reviews. 2016 ; Vol. 85, No. 7. pp. 759-793.

BibTeX

@article{cf2e096c0c76417ca1ef992fa9e81468,
title = "Synthesis and antitumour activity of 4-aminoquinazoline derivatives",
keywords = "GROWTH-FACTOR RECEPTOR, TYROSINE KINASE INHIBITORS, POTENT EGFR INHIBITORS, COMBI-TARGETING CONCEPT, TUMOR-CELL LINES, PHASE-II TRIAL, IRREVERSIBLE INHIBITORS, BIOLOGICAL EVALUATION, 4-ANILINOQUINAZOLINE DERIVATIVES, IN-VITRO",
author = "Lipunova, {Galina N.} and Nosova, {Emiliya V.} and Charushin, {Valery N.} and Chupakhin, {Oleg N.}",
year = "2016",
doi = "10.1070/RCR4591",
language = "English",
volume = "85",
pages = "759--793",
journal = "Russian Chemical Reviews",
issn = "0036-021X",
publisher = "Turpion Ltd.",
number = "7",

}

RIS

TY - JOUR

T1 - Synthesis and antitumour activity of 4-aminoquinazoline derivatives

AU - Lipunova, Galina N.

AU - Nosova, Emiliya V.

AU - Charushin, Valery N.

AU - Chupakhin, Oleg N.

PY - 2016

Y1 - 2016

KW - GROWTH-FACTOR RECEPTOR

KW - TYROSINE KINASE INHIBITORS

KW - POTENT EGFR INHIBITORS

KW - COMBI-TARGETING CONCEPT

KW - TUMOR-CELL LINES

KW - PHASE-II TRIAL

KW - IRREVERSIBLE INHIBITORS

KW - BIOLOGICAL EVALUATION

KW - 4-ANILINOQUINAZOLINE DERIVATIVES

KW - IN-VITRO

UR - http://www.scopus.com/inward/record.url?scp=84981510538&partnerID=8YFLogxK

UR - https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=tsmetrics&SrcApp=tsm_test&DestApp=WOS_CPL&DestLinkType=FullRecord&KeyUT=000380955100005

UR - http://elibrary.ru/item.asp?id=27135414

U2 - 10.1070/RCR4591

DO - 10.1070/RCR4591

M3 - Literature review

VL - 85

SP - 759

EP - 793

JO - Russian Chemical Reviews

JF - Russian Chemical Reviews

SN - 0036-021X

IS - 7

ER -

ID: 1090237